1. Home
  2. FNWB vs IMUX Comparison

FNWB vs IMUX Comparison

Compare FNWB & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNWB
  • IMUX
  • Stock Information
  • Founded
  • FNWB 1923
  • IMUX 2016
  • Country
  • FNWB United States
  • IMUX United States
  • Employees
  • FNWB N/A
  • IMUX N/A
  • Industry
  • FNWB Banks
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FNWB Finance
  • IMUX Health Care
  • Exchange
  • FNWB Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • FNWB 89.9M
  • IMUX 86.3M
  • IPO Year
  • FNWB 2015
  • IMUX N/A
  • Fundamental
  • Price
  • FNWB $10.93
  • IMUX $0.95
  • Analyst Decision
  • FNWB Hold
  • IMUX Strong Buy
  • Analyst Count
  • FNWB 1
  • IMUX 6
  • Target Price
  • FNWB $12.00
  • IMUX $12.67
  • AVG Volume (30 Days)
  • FNWB 14.1K
  • IMUX 1.0M
  • Earning Date
  • FNWB 01-29-2025
  • IMUX 02-20-2025
  • Dividend Yield
  • FNWB 2.56%
  • IMUX N/A
  • EPS Growth
  • FNWB N/A
  • IMUX N/A
  • EPS
  • FNWB N/A
  • IMUX N/A
  • Revenue
  • FNWB $50,900,000.00
  • IMUX N/A
  • Revenue This Year
  • FNWB N/A
  • IMUX N/A
  • Revenue Next Year
  • FNWB $12.62
  • IMUX N/A
  • P/E Ratio
  • FNWB N/A
  • IMUX N/A
  • Revenue Growth
  • FNWB N/A
  • IMUX N/A
  • 52 Week Low
  • FNWB $8.91
  • IMUX $0.92
  • 52 Week High
  • FNWB $16.00
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • FNWB 59.87
  • IMUX 41.06
  • Support Level
  • FNWB $10.55
  • IMUX $0.93
  • Resistance Level
  • FNWB $10.96
  • IMUX $1.02
  • Average True Range (ATR)
  • FNWB 0.24
  • IMUX 0.07
  • MACD
  • FNWB 0.04
  • IMUX 0.00
  • Stochastic Oscillator
  • FNWB 75.90
  • IMUX 27.01

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: